Interpace Diagnostics Group Company Profile (NASDAQ:IDXG)

About Interpace Diagnostics Group (NASDAQ:IDXG)

Interpace Diagnostics Group logoInterpace Diagnostics Group, Inc., formerly PDI, Inc., is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management. The Company operates through molecular diagnostics segment. It offers molecular tests, such as PancraGen, which is a pancreatic cyst molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its PathFinder platform; ThyGenX, which assesses thyroid nodules for risk of malignancy, and ThyraMIR, which assesses thyroid nodules risk of malignancy utilizing a gene expression assay. Through its molecular diagnostics business, the Company provides diagnostic options for detecting genetic and other molecular alterations that are associated with gastrointestinal and endocrine cancers, which are focused on early detection of cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Business Services
  • Sub-Industry: Health Care Services
  • Symbol: NASDAQ:IDXG
  • CUSIP: 69329V10
  • Web: www.pdi-inc.com
Capitalization:
  • Market Cap: $11.97 million
  • Outstanding Shares: 6,723,000
Average Prices:
  • 50 Day Moving Avg: $2.33
  • 200 Day Moving Avg: $2.44
  • 52 Week Range: $0.70 - $19.80
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $13.09 million
  • Price / Sales: 0.91
  • Book Value: $3.00 per share
  • Price / Book: 0.59
Profitability:
  • EBIDTA: ($9,960,000.00)
  • Net Margins: -81.73%
  • Return on Equity: -353.81%
  • Return on Assets: -40.84%
Debt:
  • Debt-to-Equity Ratio: -3.58%
  • Current Ratio: 0.34%
  • Quick Ratio: 0.34%
Misc:
  • Average Volume: 2.07 million shs.
  • Beta: 1.8
  • Short Ratio: 1.76
 

Frequently Asked Questions for Interpace Diagnostics Group (NASDAQ:IDXG)

What is Interpace Diagnostics Group's stock symbol?

Interpace Diagnostics Group trades on the NASDAQ under the ticker symbol "IDXG."

How were Interpace Diagnostics Group's earnings last quarter?

Interpace Diagnostics Group Inc (NASDAQ:IDXG) announced its earnings results on Monday, May, 15th. The company reported $0.42 earnings per share (EPS) for the quarter. The company had revenue of $3.47 million for the quarter. Interpace Diagnostics Group had a negative return on equity of 353.81% and a negative net margin of 81.73%. View Interpace Diagnostics Group's Earnings History.

Who are some of Interpace Diagnostics Group's key competitors?

Who owns Interpace Diagnostics Group stock?

Interpace Diagnostics Group's stock is owned by many different of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (0.69%) and Morgan Stanley (0.59%). View Institutional Ownership Trends for Interpace Diagnostics Group.

Who bought Interpace Diagnostics Group stock? Who is buying Interpace Diagnostics Group stock?

Interpace Diagnostics Group's stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley and Vanguard Group Inc.. View Insider Buying and Selling for Interpace Diagnostics Group.

How do I buy Interpace Diagnostics Group stock?

Shares of Interpace Diagnostics Group can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Interpace Diagnostics Group stock cost?

One share of Interpace Diagnostics Group stock can currently be purchased for approximately $1.78.

Analyst Ratings

Consensus Ratings for Interpace Diagnostics Group (NASDAQ:IDXG) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Interpace Diagnostics Group (NASDAQ:IDXG)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/21/2015William BlairReiterated RatingMarket PerformN/AView Rating Details
8/25/2015Roth CapitalReiterated RatingBuyN/AView Rating Details
(Data available from 5/25/2015 forward)

Earnings

Earnings History for Interpace Diagnostics Group (NASDAQ:IDXG)
Earnings by Quarter for Interpace Diagnostics Group (NASDAQ:IDXG)
Earnings History by Quarter for Interpace Diagnostics Group (NASDAQ:IDXG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/15/2017Q1 2017$0.42$3.47 millionViewN/AView Earnings Details
11/12/2015Q3($0.40)($0.31)$32.35 million$36.60 millionViewListenView Earnings Details
8/13/2015Q215($0.46)($0.44)$32.62 million$34.10 millionViewListenView Earnings Details
5/12/2015Q115($0.48)($0.25)$33.20 million$38.30 millionViewListenView Earnings Details
3/3/2015Q414($0.50)($0.27)$140.87 million$28.90 millionViewListenView Earnings Details
11/3/2014Q3($0.19)($0.29)$33.40 million$29.20 millionViewListenView Earnings Details
8/13/2014Q2($0.12)($0.17)$35.60 million$31.60 millionViewListenView Earnings Details
5/7/2014Q1($0.11)($0.11)$39.48 million$32.80 millionViewListenView Earnings Details
2/27/2014Q4($0.11)($0.25)$38.09 million$36.41 millionViewListenView Earnings Details
11/12/2013Q3($0.23)($0.14)ViewListenView Earnings Details
8/5/2013Q2 2013($0.11)($0.06)$35.26 million$37.20 millionViewListenView Earnings Details
3/6/2013Q4 2012($0.07)($1.64)$36.90 million$35.60 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Interpace Diagnostics Group (NASDAQ:IDXG)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Interpace Diagnostics Group (NASDAQ:IDXG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Interpace Diagnostics Group (NASDAQ:IDXG)
Insider Ownership Percentage: 2.50%
Insider Trades by Quarter for Interpace Diagnostics Group (NASDAQ:IDXG)
Institutional Ownership by Quarter for Interpace Diagnostics Group (NASDAQ:IDXG)
Insider Trades by Quarter for Interpace Diagnostics Group (NASDAQ:IDXG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/25/2014Graham G MiaoCFOBuy22,000$1.65$36,300.00View SEC Filing  
11/10/2014Nancy LurkerCEOBuy49,000$1.75$85,750.00View SEC Filing  
11/7/2014Gerald R Melillo JrInsiderBuy5,000$1.58$7,900.00View SEC Filing  
11/7/2014Jeffrey Edward SmithVPBuy200,000$1.75$350,000.00View SEC Filing  
11/6/2014Nancy LurkerCEOBuy57,000$1.74$99,180.00View SEC Filing  
11/5/2014Gerald P BelleDirectorBuy57,300$1.71$97,983.00View SEC Filing  
11/18/2013Gerald BelleDirectorBuy20,400$5.21$106,284.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Interpace Diagnostics Group (NASDAQ:IDXG)
Latest Headlines for Interpace Diagnostics Group (NASDAQ:IDXG)
Source:
DateHeadline
finance.yahoo.com logoInterpace Diagnostics Announces Launch of Enhancement to Thyroid Testing Services
finance.yahoo.com - May 24 at 5:41 PM
finance.yahoo.com logoInterpace Diagnostics Group, Inc. :IDXG-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017
finance.yahoo.com - May 24 at 11:37 AM
americanbankingnews.com logoInterpace Diagnostics Group Inc (IDXG) Releases Quarterly Earnings Results
www.americanbankingnews.com - May 16 at 4:44 PM
finance.yahoo.com logoEdited Transcript of IDXG earnings conference call or presentation 15-May-17 8:30pm GMT
finance.yahoo.com - May 16 at 11:12 AM
reuters.com logoBRIEF-Interpace Diagnostics qtrly EPS from continuing operations $0.42
www.reuters.com - May 15 at 10:57 AM
finance.yahoo.com logoInterpace Diagnostics Group Reports First Quarter 2017 Financial Results, Business Progress and Recent Accomplishments
finance.yahoo.com - May 15 at 10:57 AM
finance.yahoo.com logoInterpace Diagnostics to Host Conference Call and Webcast to Discuss First Quarter 2017 Financial Results on Monday May 15, 2017
finance.yahoo.com - May 12 at 6:31 PM
finance.yahoo.com logoInterpace Diagnostics Presents New Data on PancraGEN® at DDW
finance.yahoo.com - May 10 at 1:25 PM
streetinsider.com logoInterpace Diagnostics (IDXG) to Present New Data in Six Posters Related to PancraGEN at DDW Meeting
www.streetinsider.com - May 1 at 1:22 PM
finance.yahoo.com logoInterpace Diagnostics to Present New Data in Six Posters Related to PancraGEN™ at Upcoming Annual DDW International Meeting on May 6-9, 2017
finance.yahoo.com - May 1 at 1:22 PM
finance.yahoo.com logoInterpace Diagnostics to Present at RedChip's Global Online Growth Conference
finance.yahoo.com - April 24 at 8:48 AM
finance.yahoo.com logoInterpace Diagnostics Eliminates Long Term Secured Debt
finance.yahoo.com - April 20 at 11:33 AM
streetinsider.com logoInterpace Diagnostics (IDXG) Reports Coverage of ThyraMIR with UnitedHealthcare
www.streetinsider.com - April 19 at 10:43 PM
nasdaq.com logoMid-Afternoon Market Update: GNC Gains On Upbeat Earnings; Barracuda Shares Drop
www.nasdaq.com - April 18 at 5:22 PM
finance.yahoo.com logoInterpace Announces Coverage of ThyraMIR® with UnitedHealthcare
finance.yahoo.com - April 18 at 11:06 AM
americanbankingnews.com logoInterpace Diagnostics Group Inc (IDXG) Short Interest Up 24.8% in March
www.americanbankingnews.com - April 13 at 4:50 PM
finance.yahoo.com logoInterpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Minimum Stockholders' Equity Requirement
finance.yahoo.com - April 13 at 10:18 AM
finance.yahoo.com logoInterpace Diagnostics Group, Inc. :IDXG-US: Earnings Analysis: Q4, 2016 By the Numbers : April 11, 2017
finance.yahoo.com - April 11 at 11:57 AM
finance.yahoo.com logoA Look at Interpace Diagnostics Financials, Drug Pipeline and Market Opportunity
finance.yahoo.com - April 7 at 10:23 AM
reuters.com logoBRIEF-Interpace Diagnostics enters into waiver agreement of company's senior secured convertible note
www.reuters.com - April 4 at 2:58 AM
finance.yahoo.com logoInterpace Diagnostics Announces European Patent Approval For Underlying Technology of its ThyraMIR® microRNA Classifier
finance.yahoo.com - April 4 at 2:58 AM
investopedia.com logoInterpace Diagnostics Gets EU Patent for Thyroid Test
www.investopedia.com - April 3 at 4:03 PM
finance.yahoo.com logoInterpace Diagnostics Group Inc. to Present at The MicroCap Conference on April 4th at 9 AM in New York City at the Essex House
finance.yahoo.com - March 31 at 5:51 PM
biz.yahoo.com logoINTERPACE DIAGNOSTICS GROUP, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 31 at 5:51 PM
nasdaq.com logoBUZZ-U.S. STOCKS ON THE MOVE-ConocoPhillips, Lululemon, BiondVax Pharma, Interpace Diagnostics - Nasdaq
www.nasdaq.com - March 30 at 11:16 PM
feeds.benzinga.com logo20 Stocks Moving In Thursday's Pre-Market Session
feeds.benzinga.com - March 30 at 9:10 AM
finance.yahoo.com logoEdited Transcript of IDXG earnings conference call or presentation 29-Mar-17 8:30pm GMT
finance.yahoo.com - March 30 at 8:11 AM
finance.yahoo.com logoInterpace Diagnostics Group Reports Fourth Quarter and Full Year 2016 Financial Results, Business Progress Against Plan and Recent Accomplishments
finance.yahoo.com - March 29 at 6:23 PM
biz.yahoo.com logoINTERPACE DIAGNOSTICS GROUP, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem
biz.yahoo.com - March 29 at 6:23 PM
finance.yahoo.com logoInterpace Diagnostics Group Announces Timing of Earnings Release and Investor Conference Call
finance.yahoo.com - March 28 at 5:28 PM
americanbankingnews.com logoInterpace Diagnostics Group Inc (IDXG) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - March 27 at 7:11 AM
seekingalpha.com logoInterpace Diagnostics restructures debt in convertible stock and warrant deal; shares ease 6% premarket
seekingalpha.com - March 23 at 6:24 PM
us.rd.yahoo.com logoInterpace Diagnostics Group Announces Agreements to Successfully Restructure Debt and Terminate Royalty and Milestone Obligations
us.rd.yahoo.com - March 23 at 6:24 PM
rttnews.com logoInterpace Diagnostics Group (IDXG) Is Surging In Early Trade
www.rttnews.com - March 22 at 9:59 AM
finance.yahoo.com logoInterpace Diagnostics Participates in USA Today Endocrine Health Campaign
finance.yahoo.com - March 20 at 6:56 PM
americanbankingnews.com logoShort Interest in Interpace Diagnostics Group Inc (IDXG) Expands By 25.5%
www.americanbankingnews.com - March 13 at 10:06 AM
americanbankingnews.com logoSecure Property Development & Invest PLC (SPDI) Insider Harin Thaker Purchases 11,250 Shares
www.americanbankingnews.com - March 9 at 4:45 AM
finance.yahoo.com logoInterpace Diagnostics to Present New Data on Thyroid Product Performance
finance.yahoo.com - February 27 at 6:46 PM
streetinsider.com logoInterpace Diagnostics (IDXG) Enters into Pact with Viatar CTC Solutions - StreetInsider.com
www.streetinsider.com - February 22 at 6:01 PM
us.rd.yahoo.com logo8:01 am Interpace Diagnostics announces the initiation of a collaborative research program with Viatar CTC Solutions to detect and characterize early cancer in liquid biopsies; financial details not disclosed
us.rd.yahoo.com - February 22 at 12:42 PM
finance.yahoo.com logoInterpace Diagnostics to Present at 2017 BIO CEO & Investor Conference
finance.yahoo.com - February 10 at 6:36 PM
biz.yahoo.com logoINTERPACE DIAGNOSTICS GROUP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statement
biz.yahoo.com - February 8 at 6:35 PM
finance.yahoo.com logoInterpace Diagnostics Announces Closing of $3.9 Million Public Offering
finance.yahoo.com - February 8 at 6:35 PM
us.rd.yahoo.com logoInterpace Diagnostics Announces Pricing of Public Offering to Raise $3.6 Million
us.rd.yahoo.com - February 3 at 6:25 PM
streetinsider.com logoInterpace Diagnostics (IDXG) Plans Public Offering of Common Stock
www.streetinsider.com - February 2 at 11:34 PM
finance.yahoo.com logoInterpace Diagnostics Announces Proposed Public Offering of Common Stock
finance.yahoo.com - February 2 at 6:33 PM
reuters.com logoBRIEF-Interpace Diagnostics Group Inc says Interpace Diagnostics announces international expansion of thyroid testing
www.reuters.com - January 25 at 7:16 PM
finance.yahoo.com logoInterpace Diagnostics to Present at NobleCon13
finance.yahoo.com - January 25 at 7:16 PM
us.rd.yahoo.com logoInterpace Diagnostics Announces International Expansion of Thyroid Testing
us.rd.yahoo.com - January 24 at 11:36 PM
finance.yahoo.com logo8:06 am Interpace Diagnostics enters agreement w/ Best Med Opinion; designates Best Med as the exclusive provider of its products in Israel
finance.yahoo.com - January 22 at 5:43 PM

Social

Chart

Interpace Diagnostics Group (IDXG) Chart for Thursday, May, 25, 2017

This page was last updated on 5/25/2017 by MarketBeat.com Staff